FBIO
Fortress Biotech Inc Pref Series A
NASDAQ: FBIOP · HEALTHCARE · BIOTECHNOLOGY
$14.39
-0.21% today
Updated 2026-04-30
Market cap
$76.49M
P/E ratio
—
P/S ratio
1.21x
EPS (TTM)
$-0.86
Dividend yield
—
52W range
$6 – $15
Volume
0.0M
WallStSmart proprietary scores
28
out of 100
Grade: F
Strong Sell
Investment rating
4.0
Growth
C5.0
Quality
C+3.0
Profitability
D6.0
Valuation
B5/9
Piotroski F-Score
Moderate
-7.2
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
$14.99
Margin of safety
+24.55%
Price chart
X-Ray snapshot
Strengths
+ 24.55% below intrinsic value
Risks
- Altman Z -7.16 — distress zone
- Negative free cash flow $-12.54M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $75.74M | $84.51M | $57.67M | $63.26M | $63.26M |
| Net income | $-86.58M | $-60.64M | $-46.00M | $6.82M | $-3.94M |
| EPS | — | — | — | — | $-0.86 |
| Free cash flow | $-182.46M | $-136.32M | $-95.19M | $-65.78M | $-12.54M |
| Profit margin | -114.30% | -71.75% | -79.75% | 10.77% | 10.80% |
Peer comparison
Smart narrative
Fortress Biotech Inc Pref Series A trades at $14.39. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of -7.16, it sits in the distress. TTM revenue stands at $63.26M. with profit margins at 10.80%. Our DCF model estimates intrinsic value at $14.99.
Frequently asked questions
What is Fortress Biotech Inc Pref Series A's stock price?
Fortress Biotech Inc Pref Series A (FBIOP) trades at $14.39.
Is Fortress Biotech Inc Pref Series A overvalued?
Smart Value Score 28/100 (Grade F, Strong Sell). DCF value $14.99.
What is the price target of Fortress Biotech Inc Pref Series A (FBIOP)?
The analyst target price is $—, representing NaN% downside from the current price of $14.39.
What is the intrinsic value of Fortress Biotech Inc Pref Series A (FBIOP)?
Based on our DCF model, intrinsic value is $14.99, a +24.6% margin of safety versus $14.39.
What is Fortress Biotech Inc Pref Series A's revenue?
TTM revenue is $63.26M.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
-7.16 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.21x
ROE-108.70%
Beta1.45
50D MA$13.30
200D MA$9.69
Shares out0.06B
Float0.02B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—